Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children. [electronic resource] by
- King, J C
- Fast, P E
- Zangwill, K M
- Weinberg, G A
- Wolff, M
- Yan, L
- Newman, F
- Belshe, R B
- Kovacs, A
- Deville, J G
- Jelonek, M
Producer: 20020205
In:
The Pediatric infectious disease journal vol. 20
Availability: No items available.
|
|
15.
|
Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group. [electronic resource] by
- Graham, B S
- Keefer, M C
- McElrath, M J
- Gorse, G J
- Schwartz, D H
- Weinhold, K
- Matthews, T J
- Esterlitz, J R
- Sinangil, F
- Fast, P E
Producer: 19960814
In:
Annals of internal medicine vol. 125
Availability: No items available.
|
|
16.
|
Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults. [electronic resource] by
- King, J C
- Treanor, J
- Fast, P E
- Wolff, M
- Yan, L
- Iacuzio, D
- Readmond, B
- O'Brien, D
- Mallon, K
- Highsmith, W E
- Lambert, J S
- Belshe, R B
Producer: 20000413
In:
The Journal of infectious diseases vol. 181
Availability: No items available.
|
|
17.
|
Safety and immunogenicity of Env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59. NIAID AIDS Vaccine Evaluation Group. [electronic resource] by
- Keefer, M C
- Graham, B S
- McElrath, M J
- Matthews, T J
- Stablein, D M
- Corey, L
- Wright, P F
- Lawrence, D
- Fast, P E
- Weinhold, K
- Hsieh, R H
- Chernoff, D
- Dekker, C
- Dolin, R
Producer: 19961010
In:
AIDS research and human retroviruses vol. 12
Availability: No items available.
|
|
18.
|
A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. [electronic resource] by
- Gorse, G J
- Keefer, M C
- Belshe, R B
- Matthews, T J
- Forrest, B D
- Hsieh, R H
- Koff, W C
- Hanson, C V
- Dolin, R
- Weinhold, K J
- Frey, S E
- Ketter, N
- Fast, P E
Producer: 19960305
In:
The Journal of infectious diseases vol. 173
Availability: No items available.
|
|
19.
|
Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women. [electronic resource] by
- Wright, P F
- Lambert, J S
- Gorse, G J
- Hsieh, R H
- McElrath, M J
- Weinhold, K
- Wara, D W
- Anderson, E L
- Keefer, M C
- Jackson, S
- Wagner, L J
- Francis, D P
- Fast, P E
- McNamara, J
Producer: 19991108
In:
The Journal of infectious diseases vol. 180
Availability: No items available.
|
|
20.
|
Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group. [electronic resource] by
- Graham, B S
- McElrath, M J
- Connor, R I
- Schwartz, D H
- Gorse, G J
- Keefer, M C
- Mulligan, M J
- Matthews, T J
- Wolinsky, S M
- Montefiori, D C
- Vermund, S H
- Lambert, J S
- Corey, L
- Belshe, R B
- Dolin, R
- Wright, P F
- Korber, B T
- Wolff, M C
- Fast, P E
Producer: 19980306
In:
The Journal of infectious diseases vol. 177
Availability: No items available.
|